home / stock / elan / elan articles
Shares of Applied Therapeutics, Inc. (NASDAQ: APLT) shares fell sharply during Friday’s session after the company released topline results ...
U.S. stocks traded higher, with the Dow Jones index gaining more than 100 points on Friday. Shares of The Greenbrier Companies, Inc. (NYSE: GBX) ro...
Elanco Animal Health Inc (NYSE: ELAN) reported a Q3 FY23 revenue of $1.068 billion, up 4% reported growth or 5% excluding the impact of foreig...
News, Short Squeeze, Breakout and More Instantly...
Elanco Animal Health Incorporated Company Name:
ELAN Stock Symbol:
NYSE Market:
Elanco Animal Health Incorporated Website:
NEW YORK CITY, NY / ACCESSWIRE / July 1, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). Investors who purchased Elanco securities are encouraged to obtain additi...
2024-07-01 07:00:08 ET David Westenberg from Piper Sandler issued a price target of $16.00 for ELAN on 2024-07-01 06:25:00. The adjusted price target was set to $16.00. At the time of the announcement, ELAN was trading at $14.43. The overall price target consensus is at ...
Elanco Provides Innovation Update PR Newswire Major technical sections complete for Zenrelia, with FDA final approval on track for late in third quarter of 2024; updates on differentiation and safety Final FDA approval for Credelio Quattro now expected in the fo...